Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2019-07-14 16:37:51 UTC |
---|
Last Updated | 2019-10-01 21:41:51 UTC |
---|
CypComp ID | CC02308 |
---|
Compound Information |
---|
Name | CP-122-721 |
---|
Structure Image | |
---|
InChIKey | ZIWFCOIGUNPHPM-MJGOQNOKSA-N |
---|
PubChem ID | Not Available |
---|
CypCompound Information |
---|
Set | CypBoM Training Set |
---|
Bonds of Metabolism (BoMs) | CYP1A2 | CYP2A6 | CYP2B6 | CYP2C8 | CYP2C9 | CYP2C19 | CYP2D6 | CYP2E1 | CYP3A4 | | | | | | | - <18,17;Cleavage;R1>
- <18,H;Oxidation;R1>
| | - <8,9;Cleavage;R1>
- <8,H;Oxidation;R1>
|
|
---|
References | - Obach RS, Margolis JM, Logman MJ: In vitro metabolism of CP-122,721 ((2S,3S)-2-phenyl-3-[(5-trifluoromethoxy-2-methoxy)benzylamino]piperidine), a non-peptide antagonist of the substance P receptor. Drug Metab Pharmacokinet. 2007 Oct;22(5):336-49. [PubMed:17965517 ]
|
---|
Download File | CC02308.sdf |
---|